SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ____________ SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2) ONCOGENE SCIENCE, INC. ---------------------- (Name of Issuer) COMMON STOCK, $.01 PAR VALUE ---------------------------- (Title of Class of Securities) 682305 10 7 ----------- (CUSIP Number) (continued on following pages (s)) Page 1 of 5 pages CUSIP NO. 682305 10 7 PAGE 2 OF 5 PAGES ----------- ----------------- - ------------------------------------------------------------------------------ 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS BECTON, DICKINSON AND COMPANY - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) [_] (B) [_] NOT APPLICABLE - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION NEW JERSEY - ------------------------------------------------------------------------------ 5 SOLE VOTING POWER NONE ------------------------------------------------------------ NUMBER OF 6 SHARED VOTING POWER SHARES NONE ------------------------------------------------------------ BENEFICIALLY 7 SOLE DISPOSITIVE POWER OWNED BY EACH NONE ------------------------------------------------------------ REPORTING PERSON 8 SHARED DISPOSITIVE POWER WITH NONE - ------------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON NONE - ------------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES NOT APPLICABLE - ------------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0% - ------------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON CO - ------------------------------------------------------------------------------ CUSIP NO. 682305 10 7 PAGE 3 OF 5 PAGES ----------- ----------------- AMENDMENT NO. 2 --------------- STATEMENT ON SCHEDULE 13G PURSUANT TO RULE 13d-1(c) OF THE GENERAL RULES AND REGULATIONS UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED ITEM 1(A) NAME OF ISSUER. --------------- Oncogene Science, Inc. ITEM 1(B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES. --------------------------------------------------------- 106 Charles Lindbergh Boulevard, Uniondale, New York 11553 ITEM 2(A) NAMES OF PERSON FILING. ----------------------- Becton, Dickinson and Company ITEM 2(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR IF NONE, RESIDENCE. ------------------------------------------------------------ One Becton Drive, Franklin Lakes, New Jersey 07417-1880 ITEM 2(C) CITIZENSHIP. ------------ New Jersey ITEM 2(D) TITLE OF CLASS OF SECURITIES. ----------------------------- Common Stock, $.01 par value ITEM 2(E) CUSIP NUMBER. ------------- 682305 10 7 CUSIP NO. 682305 10 7 PAGE 4 OF 5 PAGES ----------- ----------------- ITEM 3 THIS STATEMENT IS NOT FILED PURSUANT TO RULES 13D-1(B) OR 13D-2(B). ITEM 4. OWNERSHIP. On January 31, 1997, Becton, Dickinson and Company ("Becton") disposed of all of the shares of Common Stock of Oncogene Science, Inc. which were beneficially owned by Becton. As a result of said transaction, Becton no longer beneficially owns any Common Stock of Oncogene Science, Inc. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable ITEM 10. CERTIFICATION. Not applicable CUSIP NO. 682305 10 7 PAGE 5 OF 5 PAGES ----------- ----------------- SIGNATURE --------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. BECTON, DICKINSON AND COMPANY Dated: July 17, 1997 By: /s/ BRIDGET M. HEALY --------------------- Bridget M. Healy Vice President and Secretary